Today in Focus

Pharmaceuticals: who decides the price of life?

Feb. 7, 2019

The cystic fibrosis drug Orkambi could extend the lives of thousands of children – but it comes with a price tag of £105,000 per patient per year. The NHS says it cannot afford it. Health editor Sarah Boseley explores how the cost of a life-extending drug can be weighed next to a person’s life. Plus: Natalie Nougayrède on the conspiracy theories threatening European unity. To support The Guardian’s independent journalism, visit neither hosts nor alters podcast files. All content © its respective owners.